Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2015

Apr 2, 2015

29777_rns_2015-04-02_de4cf4b4-11c7-4b60-be67-6b50ee0576ae.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Page 1 of 1

SEC FORM 4

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Check this box if no longer subject to Section 16. Form 4 or Form 5 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP obligations may continue. See Instruction 1(b).

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person*TILTON GLENN F(Last)(First)(Middle)100 ABBOTT PARK ROAD(Street)ABBOTTPARKIL60064-6400(City)(State)(Zip) 1. Name and Address of Reporting Person*TILTON GLENN F(Last)(First)(Middle)100 ABBOTT PARK ROAD(Street)ABBOTTPARKIL60064-6400(City)(State)(Zip) 1. Name and Address of Reporting Person*TILTON GLENN F(Last)(First)(Middle)100 ABBOTT PARK ROAD(Street)ABBOTTPARKIL60064-6400(City)(State)(Zip) 1. Name and Address of Reporting Person*TILTON GLENN F(Last)(First)(Middle)100 ABBOTT PARK ROAD(Street)ABBOTTPARKIL60064-6400(City)(State)(Zip) 2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT] 2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT] 2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT] 2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT] 2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT] 2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT] 2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT] 2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT] 2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT] 5. Relationship of Reporting Person(s) to Issuer(Check all applicable)XDirector10% OwnerOfficer (give titlebelow)Other (specifybelow) 5. Relationship of Reporting Person(s) to Issuer(Check all applicable)XDirector10% OwnerOfficer (give titlebelow)Other (specifybelow) 5. Relationship of Reporting Person(s) to Issuer(Check all applicable)XDirector10% OwnerOfficer (give titlebelow)Other (specifybelow) 5. Relationship of Reporting Person(s) to Issuer(Check all applicable)XDirector10% OwnerOfficer (give titlebelow)Other (specifybelow) 5. Relationship of Reporting Person(s) to Issuer(Check all applicable)XDirector10% OwnerOfficer (give titlebelow)Other (specifybelow) 5. Relationship of Reporting Person(s) to Issuer(Check all applicable)XDirector10% OwnerOfficer (give titlebelow)Other (specifybelow) 5. Relationship of Reporting Person(s) to Issuer(Check all applicable)XDirector10% OwnerOfficer (give titlebelow)Other (specifybelow) 5. Relationship of Reporting Person(s) to Issuer(Check all applicable)XDirector10% OwnerOfficer (give titlebelow)Other (specifybelow)
3. Date of Earliest Transaction (Month/Day/Year)03/31/2015
4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check ApplicableLine)XForm filed by One Reporting PersonForm filed by More than One ReportingPerson
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. TransactionDate(Month/Day/Year) 2A. DeemedExecution Date,if any(Month/Day/Year) 3.TransactionCode (Instr.8) 4. Securities Acquired(A) or Disposed Of (D)(Instr. 3, 4 and 5) 5. Amount ofSecuritiesBeneficiallyOwnedFollowingReportedTransaction(s)(Instr. 3 and 4) 6.OwnershipForm:Direct (D)or Indirect(I) (Instr. 4) 7. Natureof IndirectBeneficialOwnership(Instr. 4)
Code V Amount (A)or(D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities)
1. Title ofDerivativeSecurity(Instr. 3) 2.Conversionor ExercisePrice ofDerivativeSecurity 3. TransactionDate(Month/Day/Year) 3A. DeemedExecution Date,if any(Month/Day/Year) 4.TransactionCode (Instr.8) 5.NumberofDerivativeSecuritiesAcquired(A) orDisposedof (D)(Instr. 3, 4and 5) 6. Date Exercisable andExpiration Date(Month/Day/Year) 7. Title andAmount ofSecuritiesUnderlyingDerivative Security(Instr. 3 and 4) 8. Price ofDerivativeSecurity(Instr. 5) 9. NumberofderivativeSecuritiesBeneficiallyOwnedFollowingReportedTransaction(s) (Instr. 4) 10.OwnershipForm:Direct (D)or Indirect(I) (Instr. 4) 11. Natureof IndirectBeneficialOwnership(Instr. 4)
Code V (A) (D) DateExercisable ExpirationDate Title AmountorNumberofShares
StockEquivalentUnits $ 0(1) D
03/31/2015 A 712 (1) (1) Commonshares 712 $ 46.33 21,841(2)

Explanation of Responses:

  1. Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

  2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

John A. Berry, by Power of 04/02/2015 Attorney for Glenn F. Tilton

  • ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

  • ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

4/2/2015